# FDA 483 - Nassr, Ahmad, MD - February 07, 2020

Source: https://www.keypedia.com/records/483/nassr-ahmad-md/3081f1ae-9af9-448b-85c3-10859110b491

> FDA 483 for Nassr, Ahmad, MD on February 07, 2020. Product: device. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Nassr, Ahmad, MD
- Inspection Date: 2020-02-07
- Product Type: device
- Office Name: Minneapolis District Office
- Summary: An FDA inspection of Nassr, Ahmad, MD, a clinical investigator site in Rochester, MN, revealed significant deficiencies in the conduct of a clinical study involving investigational devices. Observations included incomplete records for device accountability and receipt, failure to reconsent subjects after protocol amendments, and incomplete source data regarding subject eligibility. These issues indicate a lack of adherence to regulatory requirements for clinical investigations.

## Related Officers

- [investigator](https://www.keypedia.com/people/nicole-c-victoria/8c5f8060-452f-4fe5-a43f-a448ec020e60)

Company: https://www.keypedia.com/companies/nassr-ahmad-md/cc3d3978-c951-4aa7-8f81-7780e7074fb7

Office: https://www.keypedia.com/offices/minneapolis-district-office/c79fc8dc-f884-48fc-ba80-2947f662511d